ROCHE REGISTRATION GMBH
- B02 - Antihemorrágicos
- HEMLIBRA solution for injection 150 mg/ml
- HEMLIBRA solution for injection 30 mg/ml
- B03 - Preparados antianémicos
- NEORECORMON powder and solvent for solution for injection 1 000 IU(8.3 µg)+1 ml
- NEORECORMON powder and solvent for solution for injection 10 000 IU(83 µg)+1 ml
- NEORECORMON powder and solvent for solution for injection 2 000 IU(16.6 µg)+1 ml
- NEORECORMON powder and solvent for solution for injection 20 000 IU(166 µg)+1 ml
- NEORECORMON powder and solvent for solution for injection 5 000 IU(41.5 µg)+1 ml
- NEORECORMON powder and solvent for solution for injection 50 000 IU(415 µg)+1 ml
- NEORECORMON powder and solvent for solution for injection 500 IU(4.15 µg)+0.5 ml
- NEORECORMON PREFILLED SYRINGE solution for injection 1 000 IU(8.3 µg)/0.3 ml
- NEORECORMON PREFILLED SYRINGE solution for injection 10 000 IU(83 µg)/0.6 ml
- NEORECORMON PREFILLED SYRINGE solution for injection 2 000 IU(16.6 µg)/0.3 ml
- NEORECORMON PREFILLED SYRINGE solution for injection 20 000 IU(166 µg)/0.6 ml
- NEORECORMON PREFILLED SYRINGE solution for injection 3 000 IU(24.9 µg)/0.3 ml
- NEORECORMON PREFILLED SYRINGE solution for injection 30 000 IU(249 µg)/0.6 ml
- NEORECORMON PREFILLED SYRINGE solution for injection 4 000 IU(33.2 µg)/0.3 ml
- NEORECORMON PREFILLED SYRINGE solution for injection 5 000 IU(41.5 µg)/0.3 ml
- NEORECORMON PREFILLED SYRINGE solution for injection 500 IU(4.15 µg)/0.3 ml
- NEORECORMON PREFILLED SYRINGE solution for injection 6 000 IU(49.8 µg)/0.3 ml
- J05 - Antivirales de uso sistémico
- FUZEON powder and solvent for solution for injection 90 mg+1 ml
- INVIRASE capsule, hard 200 mg
- INVIRASE film-coated tablet 500 mg
- TAMIFLU capsule, hard 30 mg
- TAMIFLU capsule, hard 45 mg
- TAMIFLU capsule, hard 75 mg
- TAMIFLU powder for oral suspension 12 mg/ml
- TAMIFLU powder for oral suspension 6 mg/ml
- XOFLUZA film-coated tablet 20 mg
- XOFLUZA film-coated tablet 40 mg
- J06 - Sueros inmunes e inmunoglobulinas
- RONAPREVE solution for injection 120 mg/1 ml+120 mg/1 ml
- L01 - Antineoplásicos
- ALECENSA capsule, hard 150 mg
- AVASTIN concentrate for solution for infusion 100 mg/4 ml
- AVASTIN concentrate for solution for infusion 400 mg/16 ml
- COTELLIC film-coated tablet 20 mg
- ERIVEDGE capsule, hard 150 mg
- GAVRETO capsule, hard 100 mg
- GAZYVARO concentrate for solution for infusion 1 000 mg/40 ml
- HERCEPTIN powder for solution for infusion 150 mg
- HERCEPTIN solution for injection 600 mg/5 ml
- KADCYLA powder for solution for infusion 100 mg
- KADCYLA powder for solution for infusion 160 mg
- MABTHERA concentrate for solution for infusion 100 mg/10 ml
- MABTHERA concentrate for solution for infusion 500 mg/50 ml
- MABTHERA solution for injection 120 mg/ml
- PERJETA concentrate for solution for infusion 420 mg/14 ml
- PHESGO solution for injection 1 200 mg/15 ml+600 mg/15 ml
- PHESGO solution for injection 600 mg/10 ml+600 mg/10 ml
- POLIVY powder for solution for infusion 140 mg
- POLIVY powder for solution for infusion 30 mg
- ROZLYTREK capsule, hard 100 mg
- ROZLYTREK capsule, hard 200 mg
- TARCEVA film-coated tablet 100 mg
- TARCEVA film-coated tablet 150 mg
- TARCEVA film-coated tablet 25 mg
- TECENTRIQ concentrate for solution for infusion 1 200 mg/20 ml
- TECENTRIQ concentrate for solution for infusion 840 mg/14 ml
- XELODA film-coated tablet 150 mg
- XELODA film-coated tablet 500 mg
- ZELBORAF film-coated tablet 240 mg
- L04 - Inmunosupresores
- CELLCEPT capsule, hard 250 mg
- CELLCEPT tablet 500 mg
- ENSPRYNG PREFILLED SYRINGE solution for injection 120 mg/1 ml
- ESBRIET capsule, hard 267 mg
- ESBRIET film-coated tablet 267 mg
- ESBRIET film-coated tablet 534 mg
- ESBRIET film-coated tablet 801 mg
- OCREVUS concentrate for solution for infusion 300 mg/10 ml
- ROACTEMRA concentrate for solution for infusion 200 mg/10 ml
- ROACTEMRA concentrate for solution for infusion 400 mg/20 ml
- ROACTEMRA concentrate for solution for infusion 80 mg/4 ml
- ROACTEMRA PREFILLED SYRINGE solution for injection 162 mg/0.9 ml
- M09 - Otros medicamentos para desórdenes del sistema musculoesquelético
- EVRYSDI powder for oral solution 0.75 mg/ml